Everything below describes preclinical (in-vitro and animal) findings for laboratory research only
In preclinical research, AOD9604 is primarily investigated for its selective lipolytic activitythe ability to stimulate fat breakdown (lipolysis) and inhibit fat synthesis (lipogenesis) without exhibiting the growth-promoting or diabetogenic effects of full-length growth hormone
Based on the Phase 2 trial trajectory, users may expect an additional 1-2 kg of fat loss beyond what caloric deficit alone would produce during this period
Why Researchers Compare This Product Researchers comparing AHK-cu Cosmetic/Topical 5x peptide usually check three things: supplier trust, product identification, and catalog consistency
Financially, you should know that peptides like 5-Amino-1MQ are not covered by insurance
This guide from the team at Elon Health Urgent Care in Davenport, FL covers the mild side effects, the rare risks, and who should talk with a provider first